Investors

Bioasis Technologies, Inc. is a science-driven company focused on revolutionizing science by transporting therapeutic payloads across the blood-brain barrier and into the brain. Our goal is to generate shareholder value by developing and commercializing our proprietary brain delivery technology, xB3, to make life-saving drugs brain-penetrant and deliver those drugs at a therapeutically relevant dose.

CAD
Range: 52wk Range: Volume: Avg Volume:

Most Recent Financial Reports (Canada)

Most Recent Financial Reports (US)

SEDAR Filings